New attack on lingering HPV after throat cancer treatment
NCT ID NCT05363709
Summary
This study is testing if an immunotherapy drug called balstilimab can clear the HPV virus from the blood of throat cancer patients who have finished their main treatment but still show signs of the virus. The goal is to see if clearing this leftover virus can help prevent the cancer from coming back. The study will enroll about 20 patients who have completed surgery, chemotherapy, or radiation but still have detectable HPV in their blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.